Company: SWKH
Filing Date: 2025-03-20
Form Type: 10-K
Source: 0001628280-25-013989
Chunk: 72

Company: SWK Holdings Corp
Filing Date: 2025-03-20
Form: 10-K
Item: Item 1B
Chunk 72
---
:Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding— — Common stock, $0.001 par value; 250,000,000 shares authorized; 12,213,599 and 12,497,770 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively12 12 Additional paid-in capital4,419,991 4,425,104 Accumulated deficit(4,131,313)(4,144,801)Total stockholders' equity288,690 280,315 Total liabilities and stockholders' equity$332,235 $334,254  

See accompanying notes to the consolidated financial statements.

34

SWK HOLDINGS CORPORATION

CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share data)Year Ended December 31,20242023Revenues:Finance receivable interest income, including fees$40,787 $36,346 Pharmaceutical development 3,616 1,202 Other 584 212 Total revenues44,987 37,760 Costs and expenses:Provision for credit losses12,756 1,912 Loss on impairment of intangible assets5,771 — Impairment of goodwill— 8,404 Interest expense4,685 1,849 Pharmaceutical manufacturing, research and development expense2,203 3,436 Change in fair value of acquisition-related contingent consideration(4,900)(6,300)Depreciation and amortization expense1,399 2,577 General and administrative expense11,487 11,232 Income from operations11,586 14,650 Other income (expense), netUnrealized net gain (loss) on warrants2,406 (55)Net gain (loss) on exercise and cancellation of warrants445 (799)Net loss on marketable investments(266)— Realized gain on early payment of finance receivable1,065 — Gain on revaluation of finance receivable2,495 — Realized and unrealized foreign currency transaction gains641 817 Income before income tax expense (benefit)18,372 14,613 Income tax expense (benefit)4,884 (1,274)Net income$13,488 $15,887 Net income per shareBasic